BofA raised the firm’s price target on Tempus AI (TEM) to $54 from $52 and keeps a Neutral rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...
SoFi Technologies has set a lofty bar for itself, BofA Securities argued on Monday. Analysts led by Mihir Bhatia downgraded shares of the financial-technology firm to Underperform from Neutral and ...